Updated:
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001692830, and its reported...
Overview
Satsuma Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001692830, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-28, it reported net income of USD -70,055,000; total assets of USD 54,939,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Satsuma Pharmaceuticals, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Durham, NC, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001692830
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2022USD | -$70.1M | $54.9M | $16.4M | -$51.5M | |
| FY2021USD | -$51.2M | $109.8M | $15.8M | -$43.0M | |
| FY2020USD | -$47.6M | $81.0M | $36.3M | -$42.3M | |
| FY2019USD | -$28.2M | $126.3M | $22.8M | -$29.6M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | NONE |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Satsuma Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.